Netflix shares have tumbled 38% from their 52-week high and currently trade at a historically lean price-to-earnings ratio of 32.9, raising questions about whether the stock has reached a value inflection point. Over the past month, the shares have declined a further 12% despite the company’s mid-January quarterly beat and upbeat guidance for fiscal 2026. The steep pullback contrasts sharply with the broader tech sector’s modest downturn and positions Netflix near its lowest trading multiples in five years.

The $82.7 billion proposed acquisition of key Warner Bros. Discovery assets could add approximately $52 billion of long-term debt to Netflix’s balance sheet, significantly altering its capital structure. While management argues the deal would deepen content scale and strengthen subscriber stickiness, integrating two large entertainment franchises presents execution risks. Potential challenges include content overlap, restructuring expense estimates in the high single-digit billions, and the need to retain creative talent across merged production units.

In Q4 2025 Netflix delivered $12.05 billion in revenue, up 17.6% year-over-year, and generated $0.56 of adjusted earnings per share, beating consensus by $0.01. The global subscriber base reached 325 million, contributing to a 24.5% operating margin and a 43.3% return on equity. Guidance for Q1 2026 calls for $0.76 in EPS, implying continued double-digit earnings growth. The company maintains a net margin of 24.3% and a debt-to-equity ratio of 0.51, underscoring solid fundamentals despite rising leverage risk from the proposed acquisition.

Institutional investors own roughly 81% of outstanding shares, with BI Asset Management increasing its Netflix stake by 19.8% to 51,835 shares (valued at $62.1 million) in the latest quarter. Corporate insiders have sold 1.35 million shares worth $126 million over the past three months, including significant disposals by co-founder Reed Hastings and CEO Gregory Peters. On Wall Street, two firms maintain a Strong Buy rating, 33 issue Buys and 17 Hold, yielding a consensus Moderate Buy with an average target price near 116. Analysts from Wells Fargo, UBS, Wedbush and JPMorgan have set targets between 104 and 151 while tempering expectations on valuation upside absent deal closure and clear debt reduction plans.